{"id":20347,"date":"2021-08-06T12:06:58","date_gmt":"2021-08-06T10:06:58","guid":{"rendered":"https:\/\/vilkaviskiovsb.lt\/?p=20347"},"modified":"2021-08-06T12:08:53","modified_gmt":"2021-08-06T10:08:53","slug":"20347","status":"publish","type":"post","link":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/2021\/08\/06\/20347\/","title":{"rendered":"Antrai vakcinos dozei jau galima rinktis kito gamintojo vakcin\u0105"},"content":{"rendered":"<p style=\"text-align: justify;\"><strong>Nuo \u0161iandien Kar\u0161tosios linijos 1808 operatoriai gali visus norin\u010diuosius registruoti antros vakcinos dozei, kai pasirenkama kito gamintojo vakcina nei prie\u0161 tai skiepijant pirma doze. \u0160iuo metu patvirtinti algoritmai jau leid\u017eia miksuoti \u201eComirnaty\u201c (gam. \u201eBionTech\u201c ir \u201ePfizer\u201c) ir \u201eVaxzevria\u201c (gam. \u201eAstraZeneca\u201c) vakcinas skirtingu eili\u0161kumu: pirma doz\u0117 \u201eComirnaty\u201c, antra \u2013 \u201eVaxzevria\u201c arba atvirk\u0161\u010diai. <\/strong><\/p>\n<p style=\"text-align: justify;\">Moksliniai tyrimai rodo, kad b\u016btent \u0161i\u0173 vakcin\u0173 miksas suformuoja dar didesn\u012f imunitet\u0105. Antrai vakcinos dozei si\u016bloma rinktis kit\u0105 vakcin\u0105, jei po pirmos \u201eComirnaty\u201c ar \u201eVaxzevria\u201c doz\u0117s pasirei\u0161kia stipr\u016bs \u0161alutiniai poveikiai.<\/p>\n<p style=\"text-align: justify;\">Renkantis kito gamintojo vakcin\u0105, antram skiepui asmuo gali registruotis ir skiepytis pra\u0117jus 56 dienoms po pirmo skiepo. Tiems asmenims, kurie pasirinko skiepytis skirtingomis vakcinomis, rekomenduojama antr\u0105 vakcinos doz\u0119 gauti 56\u201384 dien\u0173 intervalu, nes atlikti moksliniai tyrimai \u0161\u012f laikotarp\u012f i\u0161skiria kaip efektyviausi\u0105 imuniteto susiformavimo at\u017evilgiu.<\/p>\n<p style=\"text-align: justify;\">Jei antra COVID-19 vakcinos doz\u0117 kita vakcina, nei skiepijant pirma doze, negali b\u016bti skiepijama minimu terminu, ji skiepijama artimiausiu \u012fmanomu laiku po termino pabaigos. Gyventojai, norintys pasiskiepyti skirtinga vakcina, gali registruotis internetu adresu <a href=\"http:\/\/www.koronastop.lt\">www.koronastop.lt<\/a> arba skambindami 1808.<\/p>\n<p style=\"text-align: justify;\">Svarbu pa\u017eym\u0117ti, kad skirting\u0173 vakcin\u0173 doz\u0117s bus nurodomos ir ES Skaitmeniniame COVID pa\u017eym\u0117jime. Asmuo, pasiskiepij\u0119 pagal miksuot\u0105 schem\u0105, gal\u0117s s\u0117kmingai naudoti tiek ES Skaitmeninio COVID pa\u017eym\u0117jimo, tiek Galimybi\u0173 paso atveriamomis galimyb\u0117mis.<\/p>\n<p style=\"text-align: justify;\">Tokios mi\u0161rios skiepijimo schemos taikomos ir kitose Europos S\u0105jungos valstyb\u0117se, pavyzd\u017eiui, Pranc\u016bzijoje, Vokietijoje, Ispanijoje, \u0160vedijoje. Portugalija taiko mi\u0161ri\u0105 schem\u0105 asmenims iki 60 met\u0173 am\u017eiaus ir jei paskiepijus prima doze pasirei\u0161kia sunki nepageidaujama reakcija, Slovakija, Estija \u2013 taip pat pasirei\u0161kus sunkiai nepageidaujamai reakcijai po pirmos doz\u0117s. Belgijoje kol kas sprendimo n\u0117ra, ta\u010diau tokia praktika gali b\u016bti taikoma individualiais atvejais. Kitos \u0161alys vis dar laukia Europos vaist\u0173 agent\u016bros (EVA) sprendimo.<\/p>\n<p style=\"text-align: justify;\">\u0160i\u0105 tvark\u0105 reglamentuojant\u012f teis\u0117s akt\u0105 rasite <a href=\"https:\/\/www.e-tar.lt\/portal\/lt\/legalAct\/fdb46350468e11eb8d9fe110e148c770\/asr?fbclid=IwAR3BeJ_cvy-q-lX8I9KJFrPp-gi2yG9TES86D6edrMbacXGSp176ZDNEyeo\">\u010cIA<\/a>.<\/p>\n<p style=\"text-align: justify;\"><em><a href=\"https:\/\/sam.lrv.lt\/lt\/kontaktai-ziniasklaidai\">SAM Spaudos tarnyba<\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nuo \u0161iandien Kar\u0161tosios linijos 1808 operatoriai gali visus norin\u010diuosius registruoti antros vakcinos dozei, kai pasirenkama kito gamintojo vakcina nei prie\u0161 tai skiepijant pirma doze. \u0160iuo metu patvirtinti algoritmai jau leid\u017eia miksuoti \u201eComirnaty\u201c (gam. \u201eBionTech\u201c ir \u201ePfizer\u201c) ir \u201eVaxzevria\u201c (gam. \u201eAstraZeneca\u201c) vakcinas skirtingu eili\u0161kumu: pirma doz\u0117 \u201eComirnaty\u201c, antra \u2013 \u201eVaxzevria\u201c arba atvirk\u0161\u010diai. Moksliniai tyrimai rodo, kad&hellip;<\/p>\n","protected":false},"author":2,"featured_media":20348,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[100],"tags":[],"class_list":["post-20347","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-del-covid-19","category-100","description-off"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/s7kWFe-20347","jetpack_featured_media_url":"https:\/\/vilkaviskiovsb.lt\/wp-content\/uploads\/2021\/08\/2.png","post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts\/20347","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/comments?post=20347"}],"version-history":[{"count":2,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts\/20347\/revisions"}],"predecessor-version":[{"id":20350,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts\/20347\/revisions\/20350"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/media\/20348"}],"wp:attachment":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/media?parent=20347"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/categories?post=20347"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/tags?post=20347"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}